Fungal infections, caused by various fungi, can affect different parts of the body and present a spectrum of illnesses ranging from mild to severe. Common types include superficial infections like ringworm and athlete's foot, as well as more serious systemic infections that can impact internal organs. Risk factors for fungal infections include weakened immune systems, certain medical treatments, and environmental exposures. Candida species are common culprits, causing infections such as thrush and vaginal yeast infections. Aspergillus and Cryptococcus can lead to serious respiratory infections, particularly in immunocompromised individuals. Diagnosis involves clinical assessment and laboratory testing, with treatment varying based on the type and severity of the infection. Antifungal medications, both topical and systemic, are commonly prescribed. However, resistance to antifungal drugs is a growing concern. Preventive measures include maintaining good hygiene, avoiding prolonged exposure to damp environments, and addressing underlying health conditions. Fungal infections highlight the importance of both proper diagnosis and timely, targeted treatment to ensure favorable outcomes. Ongoing research aims to improve diagnostic methods, treatment options, and our understanding of the complex interactions between fungi and the human immune system.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States